{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:03:44Z","timestamp":1785434624893,"version":"3.56.0"},"reference-count":7,"publisher":"Associa\u00e7\u00e3o de Medicina Intensiva Brasileira","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,29]]},"DOI":"10.62675\/2965-2774.20260148","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T17:15:09Z","timestamp":1785431709000},"source":"Crossref","is-referenced-by-count":0,"title":["To: Using the 2026 Surviving Sepsis Campaign Guidelines in Practice"],"prefix":"10.62675","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2013-6151","authenticated-orcid":false,"given":"Rodolpho Augusto de Moura","family":"Pedro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3261-5603","authenticated-orcid":false,"given":"Luiz Marcelo S\u00e1","family":"Malbouisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"49293","reference":[{"key":"key20260730171503_B1","doi-asserted-by":"crossref","DOI":"10.62675\/2965-2774.20260036","article-title":"Using the 2026 Surviving Sepsis Campaign Guidelines in Practice","volume":"38","author":"Azevedo","year":"2026","unstructured":"Azevedo LC, Myatra SN, Hammond N. Using the 2026 Surviving Sepsis Campaign Guidelines in Practice. Crit Care Sci. 2026;38:e20260036.","journal-title":"Crit Care Sci"},{"issue":"11","key":"key20260730171503_B2","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181-247.","journal-title":"Intensive Care Med"},{"issue":"4","key":"key20260730171503_B3","first-page":"725","article-title":"Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2026","volume":"54","author":"Prescott","year":"2026","unstructured":"Prescott HC, Antonelli M, Alhazzani W, Moller MH, Alshamsi F, Azevedo LC, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2026. Intensive Care Med. 2026;54(4):725-812.","journal-title":"Intensive Care Med"},{"issue":"4","key":"key20260730171503_B4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.4254\/wjh.v15.i4.497","article-title":"Emerging concepts in the care of patients with cirrhosis and septic shock","volume":"15","author":"Jimenez","year":"2023","unstructured":"Jimenez JV, Garcia-Tsao G, Saffo S. Emerging concepts in the care of patients with cirrhosis and septic shock. World J Hepatol. 2023;15(4):497-514.","journal-title":"World J Hepatol"},{"issue":"4","key":"key20260730171503_B5","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s12072-021-10164-z","article-title":"Comparison of 5% human albumin and normal saline for fluid resuscitation in sepsis-induced hypotension among patients with cirrhosis (FRISC study): a randomized controlled trial","volume":"15","author":"Philips","year":"2021","unstructured":"Philips CA, Maiwall R, Sharma MK, Jindal A, Choudhury AK, Kumar G, et al. Comparison of 5% human albumin and normal saline for fluid resuscitation in sepsis-induced hypotension among patients with cirrhosis (FRISC study): a randomized controlled trial. Hepatol Int. 2021;15(4):983-94.","journal-title":"Hepatol Int"},{"issue":"3","key":"key20260730171503_B6","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jhep.2022.03.043","article-title":"A randomized-controlled trial comparing 20% albumin to plasmalyte in patients with cirrhosis and sepsis-induced hypotension [ALPS trial]","volume":"77","author":"Maiwall","year":"2022","unstructured":"Maiwall R, Kumar A, Pasupuleti SS, Hidam AK, Tevethia H, Kumar G, et al. A randomized-controlled trial comparing 20% albumin to plasmalyte in patients with cirrhosis and sepsis-induced hypotension [ALPS trial]. J Hepatol. 2022;77(3):670-82.","journal-title":"J Hepatol"},{"key":"key20260730171503_B7","author":"Brasil. Minist\u00e9rio da Sa\u00fade. Cat\u00e1logo de Materiais","year":"2024","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Cat\u00e1logo de Materiais. Rela\u00e7\u00e3o Nacional de Medicamentos Essenciais (RENAME). Gasto federal com medicamentos: Catmat\/RENAME. 2024 [citado 2026 Jul 3]. Dispon\u00edvel em: https:\/\/www.gov.br\/saude\/acl_users\/credentials_cookie_auth\/require_login?came_from=https%3A\/\/www.gov.br\/saude\/pt-br\/composicao\/sectics\/rename\/rename-2024","journal-title":"Rela\u00e7\u00e3o Nacional de Medicamentos Essenciais (RENAME). Gasto federal com medicamentos: Catmat\/RENAME"}],"container-title":["Critical Care Science"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T17:15:10Z","timestamp":1785431710000},"score":1,"resource":{"primary":{"URL":"https:\/\/criticalcarescience.org\/article\/to-using-the-2026-surviving-sepsis-campaign-guidelines-in-practice\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":7,"alternative-id":["10.62675\/2965-2774.20260148"],"URL":"https:\/\/doi.org\/10.62675\/2965-2774.20260148","relation":{},"ISSN":["2965-2774"],"issn-type":[{"value":"2965-2774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e20260148"}}